| http://www.w3.org/ns/prov#value | - This suggests the importance of genetic polymorphisms of the MMP-1 gene promoter as well as the importance of the environmental pressure of smoking on genetic predispositions in determining risk for developing IPF. Erythrocyte complement receptor 1 (CR1) is another factor of interest that has been shown to be abnormal in other fibrotic and inflammatory diseases such as sarcoidosis.
|
